Skip to content
Clinical Trials – home
Research site

Hopital Des Enfants

France 330 Avenue De Grande Bretagne, 31059 Toulouse, France

  • 20 trials recruiting
  • Neuroblastoma · Spinal muscular atrophy · Obesity
  • Adults and children

About Specializations

Hopital Des Enfants in Toulouse, France specialises in clinical trials of conditions such as Neuroblastoma, Spinal muscular atrophy, Obesity, Asthma, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology and Hematology

The medical center is at the forefront of pediatric oncology and hematology, focusing on innovative treatments for challenging conditions such as acute myeloid leukemia and neuroblastoma. Through clinical trials, the center explores the efficacy of novel drug combinations and targeted therapies to improve survival rates and quality of life for young patients.

  • Acute Myeloid Leukemia (AML)
  • High-Risk Neuroblastoma
  • Recurrent and Primary Refractory Ewing Sarcoma

By integrating cutting-edge research with clinical practice, the center aims to set new standards in the treatment of pediatric cancers.

Neurology

Specializing in pediatric neurology, the center conducts extensive research on conditions like spinal muscular atrophy and epilepsy. The focus is on developing therapies that enhance neurological function and improve patient outcomes through innovative pharmacological approaches.

  • Spinal Muscular Atrophy (SMA)
  • Childhood Epilepsy
  • Migraine Prevention

The center's commitment to neurological research is evident in its pursuit of therapies that address both the symptoms and underlying causes of these complex disorders.

Immunology and Autoimmune Diseases

Focusing on immunology and autoimmune diseases, the center is dedicated to advancing treatments for conditions such as systemic lupus erythematosus and juvenile psoriatic arthritis. Research efforts aim to refine therapeutic strategies that modulate the immune system to achieve better disease control.

  • Systemic Lupus Erythematosus (SLE)
  • Juvenile Psoriatic Arthritis
  • Childhood Idiopathic Nephrotic Syndrome

Through innovative clinical trials, the center seeks to enhance the efficacy and safety of treatments for pediatric autoimmune conditions.

Gastroenterology

The center is a leader in pediatric gastroenterology, with a focus on inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. Research initiatives aim to develop therapies that offer improved symptom management and long-term remission.

  • Ulcerative Colitis
  • Crohn's Disease

By exploring novel pharmacological agents, the center strives to provide comprehensive care that addresses both the physical and emotional needs of young patients.

Endocrinology and Growth Disorders

In the field of endocrinology, the center focuses on growth disorders such as achondroplasia and short stature conditions. Research is directed towards optimizing growth outcomes through innovative hormonal therapies and genetic interventions.

  • Achondroplasia
  • Short Stature Disorders

The center's research efforts are dedicated to improving the quality of life for children with growth disorders by advancing therapeutic options.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
330 Avenue De Grande Bretagne31059 ToulouseFrance
Recruiting now
20 trials
Conditions studied
46

More sites in ToulouseFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

48 clinical trials

Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Indacaterol Acetate
  • Sponsor:Novartis Pharma AG
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Azacitidine
  • Sponsor:Princess Maxima Center For Pediatric Oncology
Countries:FranceFrance
  • Participants:0–17 years
  • Sponsor:Merck Sharp & Dohme LLC
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Vosoritide
  • Sponsor:Biomarin Pharmaceutical Inc.
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Bevacizumab
  • Sponsor:The University Of Birmingham

Short stature

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Vosoritide
  • Sponsor:Biomarin Pharmaceutical Inc.
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Longboard Pharmaceuticals Inc.
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:MARALIXIBAT
  • Sponsor:Mirum Pharmaceuticals Inc.
Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Harmony Biosciences LLC
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anhydrous Docetaxel
  • Sponsor:The University Of Birmingham
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Crisantaspase
  • Sponsor:Pfizer Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.